Laddar...
Xenon in the treatment of panic disorder: an open label study
BACKGROUND: Current treatments of panic disorder (PD) are limited by adverse effects, poor efficacy, and need for chronic administration. The established safety profile of subanesthetic concentrations of xenon gas, which is known to act as a glutamate subtype NMDA receptor antagonist, coupled with p...
Sparad:
| I publikationen: | J Transl Med |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5470223/ https://ncbi.nlm.nih.gov/pubmed/28610592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1237-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|